1. Home
  2. EFSC vs NAMS Comparison

EFSC vs NAMS Comparison

Compare EFSC & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EFSC
  • NAMS
  • Stock Information
  • Founded
  • EFSC 1988
  • NAMS 2019
  • Country
  • EFSC United States
  • NAMS Netherlands
  • Employees
  • EFSC N/A
  • NAMS N/A
  • Industry
  • EFSC Major Banks
  • NAMS Biotechnology: Pharmaceutical Preparations
  • Sector
  • EFSC Finance
  • NAMS Health Care
  • Exchange
  • EFSC Nasdaq
  • NAMS Nasdaq
  • Market Cap
  • EFSC 2.0B
  • NAMS 2.2B
  • IPO Year
  • EFSC 1999
  • NAMS N/A
  • Fundamental
  • Price
  • EFSC $52.94
  • NAMS $18.11
  • Analyst Decision
  • EFSC Strong Buy
  • NAMS Strong Buy
  • Analyst Count
  • EFSC 3
  • NAMS 6
  • Target Price
  • EFSC $64.33
  • NAMS $42.83
  • AVG Volume (30 Days)
  • EFSC 155.6K
  • NAMS 694.5K
  • Earning Date
  • EFSC 07-21-2025
  • NAMS 05-08-2025
  • Dividend Yield
  • EFSC 2.15%
  • NAMS N/A
  • EPS Growth
  • EFSC 9.23
  • NAMS N/A
  • EPS
  • EFSC 5.09
  • NAMS N/A
  • Revenue
  • EFSC $619,222,000.00
  • NAMS $47,140,000.00
  • Revenue This Year
  • EFSC $13.89
  • NAMS N/A
  • Revenue Next Year
  • EFSC $4.85
  • NAMS N/A
  • P/E Ratio
  • EFSC $10.40
  • NAMS N/A
  • Revenue Growth
  • EFSC 6.50
  • NAMS 586.97
  • 52 Week Low
  • EFSC $37.31
  • NAMS $14.06
  • 52 Week High
  • EFSC $63.13
  • NAMS $27.29
  • Technical
  • Relative Strength Index (RSI)
  • EFSC 49.26
  • NAMS 47.80
  • Support Level
  • EFSC $50.88
  • NAMS $16.79
  • Resistance Level
  • EFSC $53.94
  • NAMS $19.58
  • Average True Range (ATR)
  • EFSC 1.07
  • NAMS 0.94
  • MACD
  • EFSC -0.16
  • NAMS -0.12
  • Stochastic Oscillator
  • EFSC 40.79
  • NAMS 47.07

About EFSC Enterprise Financial Services Corporation

Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Share on Social Networks: